« Return to News | CROs/Service Providers

MakroCare partners with LSK in Asian, US markets

Tuesday, September 6, 2011 02:28 PM

A new alliance between MakroCare and LSK Global Pharmaceutical Services offers a single entry point to a range of drug development and commercialization services in key Asian markets as well as the US, according to PharmaTimes.

MakroCare’s home base is Hyderabad, India and LSK Global’s headquarters are in Seoul, Korea. Both are active in the US and various European markets, while MakroCare also has a presence in Western Europe.

The alliance agreement enables the two companies to offer a broad spread of services to pharmaceutical, biotechnology and medical device companies in key Asian territories, MakroCare said.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.